RecruitingNot ApplicableNCT06028139

Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes

Continuous Assessment of Risk and Efficacy (CARE) Using Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes

Sponsor

Singapore General Hospital

Enrollment

400 participants

Start Date

Oct 24, 2023

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus, Type 2

Summary

Lifestyle change is key to diabetes management but there are limited resources and time to support patients in improving lifestyle behaviour in the current healthcare system. Currently, health coaching for behavioural chance guided by continuous glucose data, wearable and lifestyle data is not available in primary and tertiary care management of diabetes. This parallel-group randomised controlled trial (RCT) aims to investigate the effectiveness of a novel multi-component model of care comprising interventions including the mobile app EMPOWER and smartwatch, health coaching, and continuous glucose monitoring (CGM).

Eligibility

Min Age: 21 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a combination of health coaching, continuous glucose monitoring (CGM — a wearable device that tracks blood sugar in real time), and an AI-powered mobile app to help people with type 2 diabetes better manage their condition. The goal is to see whether this personalized digital support system improves blood sugar control. **You may be eligible if...** - You are 21 years of age or older - You have been diagnosed with type 2 diabetes - You have a smartphone compatible with near-field communication (NFC) - You are able to do light physical activity such as walking **You may NOT be eligible if...** - You have significant cognitive impairment that would prevent you from using the app or monitoring device - You have another medical condition that would prevent you from wearing the glucose monitor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALContinuous glucose monitoring and health coaching

Each CGM device will work for 14 days. The participants will use the CGM devices for the first two-week period in the first three months of the trial, and the first two-week period of the second three months of the trial. Participants will interact with health coach throughout the study duration.

BEHAVIORALEMPOWER mobile app

Nudges will be delivered through the EMPOWER mobile app. Participants will log lifestyle information such as diet and physical activity, and clinical information such as medication and HbA1c levels through the EMPOWER mobile app.